Arief S. Gunawan

Guys And St
London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

Regulation of BCR-mediated Ca2+ mobilization by MIZ1-TMBIM4 safeguards IgG1+ GC B cell-positive selection.

Regulation of BCR-mediated Ca2+ mobilization by MIZ1-TMBIM4 safeguards IgG1+ GC B cell-positive selection.

Journal: Science immunology

Published: April 05, 2024

PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma.

PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma.

Journal: The Journal of clinical investigation

Published: February 15, 2024

PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma.

PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma.

Journal: The Journal of clinical investigation

Published: July 26, 2021

Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP.

Infection-related morbidity and mortality among older patients with DLBCL treated with full- or attenuated-dose R-CHOP.

Journal: Blood advances

Published: January 18, 2021

Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma.

Fractures are common within 18 months following first-line R-CHOP in older patients with diffuse large B-cell lymphoma.

Journal: Blood advances

Published: June 05, 2020

Restriction of memory B cell differentiation at the germinal center B cell positive selection stage.

Restriction of memory B cell differentiation at the germinal center B cell positive selection stage.

Journal: The Journal of experimental medicine

Published: October 10, 2019

Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R-CHOP.

Male gender is an independent predictor for worse survival and relapse in a large, consecutive cohort of elderly DLBCL patients treated with R-CHOP.

Journal: British journal of haematology

Published: April 26, 2019

Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity.

Stand-alone intrathecal central nervous system (CNS) prophylaxis provide unclear benefit in reducing CNS relapse risk in elderly DLBCL patients treated with R-CHOP and is associated increased infection-related toxicity.

Journal: British journal of haematology

Published: March 18, 2019

Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age.

Impact of intended and relative dose intensity of R-CHOP in a large, consecutive cohort of elderly diffuse large B-cell lymphoma patients treated with curative intent: no difference in cumulative incidence of relapse comparing patients by age.

Journal: Journal of internal medicine

Published: February 28, 2019

Ruxolitinib for the Treatment of Essential Thrombocythemia.

Ruxolitinib for the Treatment of Essential Thrombocythemia.

Journal: HemaSphere

Published: April 18, 2018

Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemia.

Ruxolitinib, a potent JAK1/JAK2 inhibitor, induces temporary reductions in the allelic burden of concurrent CSF3R mutations in chronic neutrophilic leukemia.

Journal: Haematologica

Published: March 18, 2017

Showing 1-11 of 11

Last Updated: 09/26/2026